Benzinga··Evette MitkovEnveric Surges 106% on Trump's Psychedelics Push, but Downtrend Lingers
$ENVB surges 106% after Trump orders federal acceleration of psychedelic treatment approvals and commits $50M to ibogaine research, though stock remains deeply depressed technically.
ENVBbiotechregulatory approval